<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145336</url>
  </required_header>
  <id_info>
    <org_study_id>KY20191010-2</org_study_id>
    <nct_id>NCT04145336</nct_id>
  </id_info>
  <brief_title>7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients</brief_title>
  <official_title>7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients: a Multicentre, Single-blinded, Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute pancreatitis is the most common complication of endoscopic retrograde
      cholangiopancreatography (ERCP). The incidence of post-ERCP pancreatitis (PEP) is estimated
      to be 10% to 15% in high-risk patients. Current guidelines recommend using pancreatic duct
      stent (PDS) for PEP prevention in high-risk patients, but it is not clear whether stent
      length will affect the effect of PEP prevention. The longer PDS will remain in the pancreatic
      duct for a longer period of time, thereby ensuring prolonged decompression with subsequent
      lowering of the risk for PEP. Findings from two retrospective studies showed that longer PDS
      was more effective in reducing the risk of post-ERCP hyperamylasemia and the frequency of PEP
      compared with the shorter PDS. We conducted this trial to test whether 7cm PDS was superior
      to 5cm PDS in PEP prevention in high-risk patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-ERCP Pancreatitis</measure>
    <time_frame>14 days</time_frame>
    <description>The diagnosis of PEP was established if there was new onset of upper abdominal pain associated with an increased serum amylase level of at least 3 times the upper limit of normal range at 24 hours after the procedure, and hospitalization for at least 2 nights.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Moderate to severe PEP</measure>
    <time_frame>14 days</time_frame>
    <description>The severity classification of pancreatitis was defined according to the criteria of Cotton et al and the revised Atlanta criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications of ERCP</measure>
    <time_frame>14 days</time_frame>
    <description>Other complications include post sphincterotomy bleeding, biliary infection, perforation, and any adverse outcomes possibly related to ERCP that required hospital admission or a prolonged hospital stay for further management.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Post-ERCP Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>5cm PDS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All patients in this group receive 5cm 5-Fr PDS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7cm PDS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients in this group receive 7cm 5-Fr PDS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>5cm 5-Fr PDS</intervention_name>
    <description>High-risk patients receive 5cm 5-Fr PDS</description>
    <arm_group_label>5cm PDS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>7cm 5-Fr PDS</intervention_name>
    <description>High-risk patients receive 7cm 5-Fr PDS</description>
    <arm_group_label>7cm PDS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indomethacin</intervention_name>
    <description>All patients without contraindications should be administrated with rectal indomethacin within 30 min before ERCP.</description>
    <arm_group_label>5cm PDS group</arm_group_label>
    <arm_group_label>7cm PDS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Un-intentional pancreatic duct cannulation:

               -  2 or more times;

               -  1 time with more than 10 minutes cannulation.

          2. Double-wire technique;

          3. High-risk patients:

        met at least 1 of the major criteria

          -  Clinical suspicion of sphincter of Oddi dysfunction;

          -  Pancreatic sphincterotomy

          -  Delayed precut sphincterotomy

          -  ≥ 8 cannulation attempts

          -  Pneumatic dilatation of an intact biliary sphincter

          -  Ampullectomy

        or met at least 2 or more of the minor criteria

          -  Age &lt; 50;

          -  Female;

          -  Normal TBIL;

          -  ≥ 3 injections of contrast into the pancreatic duct with ≥ 1 injection to the tail of
             the pancreas;

        Exclusion Criteria:

          -  Therapeutic PDS;

          -  Acute pancreatitis within 3 days;

          -  With a history of pancreatic surgery or biliary-enteric anastomosis;

          -  Pregnant or breastfeeding women;

          -  unwilling or inability to provide consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Xijing Hospital of Digestive Diseases</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Domagk D, Oppong KW, Aabakken L, Czakó L, Gyökeres T, Manes G, Meier P, Poley JW, Ponchon T, Tringali A, Bellisario C, Minozzi S, Senore C, Bennett C, Bretthauer M, Hassan C, Kaminski MF, Dinis-Ribeiro M, Rees CJ, Spada C, Valori R, Bisschops R, Rutter MD. Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2018 Nov;50(11):1116-1127. doi: 10.1055/a-0749-8767. Epub 2018 Oct 19.</citation>
    <PMID>30340220</PMID>
  </reference>
  <reference>
    <citation>Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Watanabe K, Nakamura J, Kikuchi H, Waragai Y, Takasumi M, Hikichi T, Ohira H. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail. World J Gastroenterol. 2018 Jun 14;24(22):2392-2399. doi: 10.3748/wjg.v24.i22.2392.</citation>
    <PMID>29904246</PMID>
  </reference>
  <reference>
    <citation>Olsson G, Lübbe J, Arnelo U, Jonas E, Törnqvist B, Lundell L, Enochsson L. The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study. United European Gastroenterol J. 2017 Feb;5(1):111-118. doi: 10.1177/2050640616645434. Epub 2016 Jul 8.</citation>
    <PMID>28405329</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>October 28, 2019</last_update_submitted>
  <last_update_submitted_qc>October 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Yanglin Pan</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>PEP</keyword>
  <keyword>Post-ERCP pancreatitis</keyword>
  <keyword>Pancreatic duct stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Indomethacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

